Cancer Upgrade Benefit will cease once a claim is paid and your premiums will reduce accordingly. If at claim time, the life assured does not have a base Living Assurance Benefit, no Optional Early Cancer Upgrade Benefit will be payable and any premiums paid for the Optional Early Cancer Upgrade Benefit after the base Living Assurance Benefit has been cancelled will be refunded to the policy owner. The amount payable under the Optional Early Cancer Upgrade Benefit is 25% of the Comprehensive Living Assurance Benefit sum assured at the date cover commences under the Optional Early Cancer Upgrade Benefit, subject to a maximum of $75,000 per life assured across all Sovereign policies . The amount payable under the Optional Early Cancer Upgrade Benefit does not change with any subsequent changes in the Comprehensive Living Assurance Benefit sum assured, such as changes due to: annual indexation increases after the date cover commences under the Optional Early Cancer Upgrade Benefit;
Malignant tumour of the prostate histologically described as TNM classification T1 or has a Gleason score of 5 or less for which treatment is not considered medically necessary, and undertaken by an appropriate specialist to arrest the spread of malignancy including but not limited to prostatectomy, chemotherapy, radiotherapy, or surgery. The Optional Early Cancer Upgrade Benefit will cease when cover under the Comprehensive Living Assurance Benefit ceases. Where the life assured has the Optional Living Assurance Buyback Benefit, the Optional Early Cancer Upgrade Benefit can be reinstated in addition to their Living Assurance Buyback Benefit, subject to the life assured satisfying the terms of the Optional Living Assurance Buyback Benefit.
The Optional Living Assurance Buyback Benefit cannot be used to reinstate the Optional Early Cancer Upgrade Benefit.
13. Optional Total Permanent Disablement condition
cover added using the Optional Business Safeguard Facility;
reductions in the Comprehensive Living Assurance Benefit sum assured due to voluntary reduction or due to a partial payment claim. Payment of the Optional Early Cancer Upgrade Benefit may be in addition to any other payments made under this policy. Payment of the Optional Early Cancer Upgrade Benefit will not reduce the Comprehensive Living Assurance Benefit sum assured. The Optional Early Cancer Upgrade Benefit covers carcinoma-in-situ of the following sites and is defined as a focal autonomous new growth of carcinomatous cells which has not yet resulted in the invasion of normal tissue. ‘Invasion’ means an infiltration and/or active destruction of normal tissue beyond the basement membrane. The carcinoma-in-situ must be positively diagnosed by biopsy and be classified as TIS according to the TNM staging method or FIGO Stage 0:
The Optional Total Permanent Disablement condition applies only if shown in the schedule and, subject to the provisions of this appendix , is included as a full payment condition under the Comprehensive Living Assurance Benefit. The Optional Total Permanent Disablement condition does not apply to any child of a life assured covered under the Children’s Trauma Benefit or the Optional Children’s and Maternity Benefit.
The Optional Total Permanent Disablement condition does not apply once the life assured attains age 65.
14. Optional Children’s and Maternity Benefit
The Optional Children’s and Maternity Benefit applies only if shown in the schedule .
The Benefit is payable in addition to any Benefit payable under the Children’s Trauma Benefit or the Newborn Children’s Benefit.
Breast.
Cervix.
Vagina.
Children’s Critical Conditions Benefit
Vulva.
What is the Children’s Critical Conditions Benefit?
Ovary.
Sovereign will pay a Children’s Critical Conditions Benefit if a child of a life assured suffers one of the applicable conditions listed in Section 1 of this appendix .
Fallopian tube: tumour limited to tubal mucosa.
The Optional Early Cancer Upgrade Benefit also covers the following cancers:
This Benefit is only payable if the child of the life assured :
Chronic lymphocytic leukaemia: where there must be the presence of chronic lymphocytic leukaemia which is histologically described as at least RAI Stage 0. Malignant melanoma which is determined by histological examination to be less than Clark Level 3 depth of invasion, and less than 1.0mm maximum thickness as measured using the Breslow method, and shows no evidence of ulceration.
first suffers a condition after the risk commencement date , subject to the three month stand down period provisions where these apply;
is aged from three months up to their 21 st birthday at the time he or she first suffers from that condition ; and
survives for at least 14 days after suffering from the condition .
852 TCB-LAC version 19 Effective 12 May 2026
Page 8 of 27
Powered by FlippingBook